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New vaccine design approaches would be greatly facilitated by a better understanding 
of the early systemic changes, and those that occur at the site of injection, responsi-
ble for the installation of a durable and oriented protective response. We performed a 
detailed characterization of very early infection and host response events following the 
intradermal administration of the modified vaccinia virus Ankara as a live attenuated 
vaccine model in non-human primates. Integrated analysis of the data obtained from 
in vivo imaging, histology, flow cytometry, multiplex cytokine, and transcriptomic analysis 
using tools derived from systems biology, such as co-expression networks, showed 
a strong early local and systemic inflammatory response that peaked at 24 h, which 
was then progressively replaced by an adaptive response during the installation of the 
host response to the vaccine. Granulocytes, macrophages, and monocytoid cells were 
massively recruited during the local innate response in association with local productions 
of GM-CSF, IL-1β, MIP1α, MIP1β, and TNFα. We also observed a rapid and transient 
granulocyte recruitment and the release of IL-6 and IL-1RA, followed by a persistent 
phase involving inflammatory monocytes. This systemic inflammation was confirmed by 
molecular signatures, such as upregulations of IL-6 and TNF pathways and acute phase 
response signaling. Such comprehensive approaches improve our understanding of the 
spatiotemporal orchestration of vaccine-elicited immune response, in a live-attenuated 
vaccine model, and thus contribute to rational vaccine development.
Keywords: vaccine, modified virus ankara, inflammation, systems biology, non-human primate, skin, lymph node, 
blood
inTrODUcTiOn
Vaccine innovation would be aided by a better understanding of the basic mechanisms associated 
with processes that affect the duration, breadth, and efficiency of the host response, particularly the 
very early events that can be manipulated by antigen targeting, adjuvants and immune stimulants, 
dose, and delivery. Focusing on very early steps of the host response may also aid in finding ways 
to reduce reactogenicity to injected-material, which may limit vaccination acceptance, particularly 
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for young children. Vaccination strategies have been improved by 
taking advantage of recent knowledge on pathogen sensing by key 
cells, such as dendritic cells (DCs), through pattern recognition 
receptors (PRRs) (1, 2). We and others have demonstrated that 
modifying the targeting of vaccine antigens to various DC recep-
tors or blocking key cytokines at the injection site significantly 
affects the induced adaptive immune response (3–6). The inter-
play between innate and adaptive immunity is characterized by 
many other highly dynamic molecular and cellular modifications. 
Emerging ‘omic technologies may help to increase our knowledge 
and aid in the development of new immunization strategies (7, 8). 
The innate response in the blood can be triggered as early as 24 h 
after immunization when using adjuvants such as alum or toll-
like receptor (TLR) (9) or after immunization with Modified virus 
Ankara (MVA) (10–13). These works suggest that very early events 
can have a strong impact to long-term responses to vaccines.
Skin is an ideal target for vaccine injection due to the diversity 
of resident and recruited immune cells, including macrophages, 
Langerhans cells, and several subsets of dermal DCs (14, 15). 
These cells, which express a wide variety of PRRs (16), can be 
used to tune the immune profiles of vaccines (17). Nevertheless, 
despite many advantages, intradermal (i.d.) route remains rarely 
used in the medical field due to the lack of reliability of the 
immunization technique (18). It remains, however, widely used 
in anti-tuberculosis vaccination to minimize the toxicity of the 
Bacille Calmette et Guérin (19), and for rabies vaccines (20). In 
addition, i.d. route may contribute to dose sparing (21–23), due 
to the efficiency of local antigen-presenting cells (APCs) (6, 10), 
which could provide a decisive advantage for products with scale-
up production constraints. Delivery technologies are developed 
in order to enable skin vaccination (24).
Here, we characterized the early responses induced by i.d. 
injection of the MVA (25) attenuated vaccine into non-human 
primates (NHPs). This attenuated vaccinia virus has been safely 
used as a Smallpox vaccine in humans (26) and is a promising 
vector for recombinant vaccines (27–30). This vaccine has been 
found to be well tolerated and highly immunogenic, making it a 
good model of attenuated vaccine to describe immune responses. 
The use of NHPs was particularly relevant because the organiza-
tion of their immune system is highly similar to that of humans 
and their response following vaccination is highly predictive of 
the response in humans (31–33).
In this study, we aimed to better understand the impact of early 
innate parameters on the elaboration of the adaptive response in 
a live attenuated vaccine model administered in the skin. The first 
step of the study consisted in an in-depth characterization of the 
innate immune responses in key localizations, i.e., injection site, 
lymph node (LN), and blood. The second step was to integrate 
data by using tools derived from systems vaccinology to identify 
key factors and to improve the knowledge of the dynamic of the 
interactions between immune parameters.
MaTerials anD MeThODs
ethics statement
Adult male cynomolgus macaques (Macaca fascicularis), 
imported from Mauritius, weighing from 4 to 6 kg, were housed 
in the CEA animal facilities (Fontenay-aux-Roses, France). The 
macaques were handled in accordance with national regulations 
(Permit Number A 92-32-02), in compliance with the Standards 
of the Office for Laboratory Animal Welfare (OLAW) under 
Assurance number A5826-01, and the European Directive 
(2010/63, recommendation No. 9). This project received the 
government authorization Number 12-013. Interventions were 
performed by veterinarians and staff of the “Animal Science and 
Welfare” core facility after sedation with ketamine hydrochloride 
(10 mg/kg, Imalgen®, Rhône-Mérieux, Lyon, France).
intradermal immunization
Prior to injection, the skin was shaved or depilated and cleaned 
with ethanol 70%. Each animal simultaneously received a total of 
10 i.d. injections containing 4 × 107 PFU each of a rMVA express-
ing eGFP (MVATG15938, Transgene SA, Illkirch-Graffenstaden, 
France) in 200  µl, equally divided between two areas: (i) 5 to 
10 cm from the left inguinal LN and (ii) on the top left of the back.
Tissue and Blood samples
Prior to biopsies, the skin and inguinal area were cleaned with 
povidone iodate solution (Vetedine®, Vetoquinol SA, Lure, 
France). Biopsies of 8 mm in diameter were collected at untreated 
sites and 24, 48, and 72 h after injection. A total of eight skin biop-
sies were performed for each animal (Figure S1 in Supplementary 
Material). These biopsies induced insignificant inflammatory 
responses in comparison to i.d. injection of MVA (Figure S2 in 
Supplementary Material). The inguinal LNs were collected 24 h 
post injection. Blood was collected in K3-EDTA tubes (Greiner 
Bio-One, Frickenhausen, Germany) for cell blood counting 
(HmX, Beckman Coulter, Roissy, France), plasma collection, and 
flow cytometry. Plasma for cytokine analysis was collected after 
10 min of centrifugation at 2,000 g. Blood (500 µl) collected in 
lithium heparin (Vacutainer BD) was mixed with 1 ml tempus 
RNA (Thermofischer Scientific, Waltham, MA, USA) for tran-
scriptomic analysis. Tissue biopsies for transcriptomic profiling 
were preserved in 1  ml RNA later solution (Qiagen, Hilden, 
Germany) at 4°C overnight and then stored at −20°C.
extraction of cells From Tissue Biopsies
Skin and LN biopsies were washed with PBS, weighed, cut into 
small pieces, and digested at 37°C under agitation (80 rpm) for 60 
and 15 min, respectively, in 2 ml DMEM (Thermofischer Scientific) 
supplemented with 5% FCS (Lonza, Basel, Switzerland), 1% 
Penicillin/Streptomycin/Neomycin (Thermofischer Scientific), 
10 mM Hepes (Thermofischer Scientific), 2 mg/ml collagenase 
D (Roche, Basel, Switzerland), and 0.02 mg/ml DNAse I (Roche). 
Tissue was then filtered using a 70-µm cell strainer and centri-
fuged. Supernatants were collected for cytokine analysis. Leftover 
tissue was shredded using a GentleMACs® dissociator (Miltenyi 
Biotec, Paris, France). The cell suspension was then washed with 
PBS and stained for flow cytometry analysis.
Flow cytometry
All steps of the staining were performed at 4°C. Cell suspensions 
were first stained with viability dye LiveDead® (Thermofischer 
Scientific) for 15 min, then washed with PBS. Fc receptors were 
TaBle 1 | Panels of antibodies used for flow cytometry staining.
specificity clone Flurochrome of the ab in the mix for
skin cells ln cells Blood
CD1a O10 AF700 AF700 N/A
HLA-DR G46-6 APC-Cy7 APC-Cy7 V500
CD163 GHI/61 BV711 BV711 N/A
CD11c 3.9 BV510 BV510 PE-Cy7
CD45 DO58-1283 PerCp N/A N/A
CD123 7G3 N/A PercP PercP
CD66abce TET2 APC APC FITC
CD3 SP34-2 V450 V450 APC-Cy7
CD8 RPA-T8 N/A N/A BV650
CD20 2H7 V450 V450 APC-Cy7
CD11b Bear 1 PE-Cy7 PE-Cy7 A700
CD16 3G8 ECD ECD APC
NKG2a Z199 PE PE PE
CD14 M5E2 N/A N/A V450
CD33 AC104.3E3 N/A N/A PE
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blocked using PBS supplemented with 5% macaque serum for 
20 min. Cell suspensions were stained for 30 min with 90 µl anti-
body mix (Table 1) diluted in BD Horizon Brilliant® Stain Buffer 
(BD Biosciences, Franklin Lakes, NJ, USA). Cells were then 
washed twice in PBS and fixed using 150 µl BD Cellfix® (BD). 
Red blood cells were removed with 1 ml BD FACs Lysing® (BD) 
for 10 min at room temperature and washed twice with PBS. The 
data were normalized to the weight of the initial biopsy for the 
analysis of cell suspensions from tissues. Data from blood cells 
were normalized to the complete blood counts. The design of the 
cytometry panel and the rationale for gating strategies (Figure S3 
in Supplementary Material) has been previously described (34).
confocal Time-lapse Microscopy  
of rMVa infection in the skin
Ten micrograms of anti-HLA-DR AF700 (Biolegend) diluted in 
PBS were injected i.d., at the same time as the rMVA-eGFP injec-
tion, 4 h prior to biopsy at each injection site destined for confocal 
video-microscopy. Following fat tissue removal, skin biopsies were 
imaged for 18 h as previously published (35). The number of GFP+ 
cells and HLA-DR+ cells was calculated using Volocity® software 
(PerkinElmer, Coventry, England) after applying a fine filter and 
then excluding objects below 200 µm3 and those above 4,000 µm3.
In Vivo Fibered confocal Fluorescence 
Microscopy (FcFM) for rMVa Visualization 
in the skin
In vivo FCFM was performed with a fibered confocal fluorescence 
microscope (Cellvizio®, Mauna Kea Technologies®, Paris, France). 
A probe that records the green fluorescence signal at 488 nm by 
sweeping the site of interest was applied two times during 30 s 
(36). GFP+ objects were counted in each frame (size > 20 μm2) 
using ImageJ® software (37). The analysis was performed on the 
50 frames containing the highest number of GFP+ objects for each 
observed site. For each time-point, the number of fluorescent 
cells of up to three injection sites was measured and is expressed 
as the mean ± SD of GFP+ cells.
histopathology
Skin and LN samples were fixed at 4°C in 4% paraformaldehyde 
for 24 h. Samples were stored in PBS at 4°C. Paraffin inclusion was 
performed using a Microm HMS740 (ThermoFischer Scientific) 
automated system by successively replacing the PBS with alco-
hol, xylene, and paraffin. The tissue was cut afterward using a 
microtome and deposited on slides. Hemalun Eosin coloration 
was performed using a Microm HMS740, alternating between 
xylene, alcohol, Hematoxylin (Labonord, Templemars, France), 
and Eosin (VWR international, Fontenay-sous-Bois, France) 
baths.
immunohistochemistry
Prior to staining, slides with 3 µm slices were incubated at 37°C 
overnight. Paraffin was removed by washing the slides with 
increasing concentrations of xylene (VWR), then ethanol (VWR), 
and water using a Microm HMS740. Unmasking was performed 
using citrate tempus (Diagnostic Biosystems, Pleasanton, CA, 
USA) in a 95°C bath for 20 min. The slides were then subjected to 
peroxidase blocking using 3% dihydrogenated water for 10 min 
(Sigma Aldrich, Saint-Louis, MO, USA) and saturated using 10% 
normal horse serum (Vector laboratories, Burlingame, CA, USA) 
and 5% BSA (Sigma Aldrich) in PBS for 30 min. Primary staining 
with anti-GFP antibody (7.5 µg per slide) in saturation solution 
(Abcam, Cambridge, UK) was then performed for 90  min fol-
lowed by secondary staining with biotinylated anti chicken IgG 
antibody (Abcam) 1/200 in PBS for 30 min. ABC Complex using 
the Vectastain ABC Kit standard Elite (Vector) and diamin-
obenzidin (Vector) were applied to the slides following supplier 
recommendations for 30 and 5  min, respectively. Slides were 
then colored using a Microm HMS740 to successively transfer 
the slides to baths containing hematoxylin, water, and increasing 
concentrations of ethanol and xylene. The slides were washed 
three times for 5 min in a bath containing PBS between each step 
of the procedure.
local and systemic cytokine releasing 
analysis
Supernatants of the digestion medium of LN, skin, and plasma were 
stored at −80°C. Cytokine levels were measured using a 23-plex 
MAP NHP Immunoassay kit PCYTMG-40K-PX23® (Millipore, 
Billerica, MA, USA) according to supplier instructions.
rna isolation and Microarray Profiles
Biopsies were immediately immersed in 1/100 RLT-beta-
mercaptoethanol lysis buffer (Qiagen, Courtaboeuf Cedex, France) 
and then disrupted and homogenized using a TissueLyser LT 
(Qiagen) and the RNA purified using a Qiagen RNeasy Micro Kit. 
Whole blood RNA was recovered in tempus tubes (ThermoFisher 
scientific) and RNA purified using the Tempus™ Spin RNA 
Isolation Kit (ThermoFisher scientific). For both purifications, 
contaminating DNA was removed using the RNA Cleanup step 
of the RNeasy Micro Kit. Purified RNA was quantified using an 
ND-8000 spectrophotometer (NanoDrop Technologies, Fisher 
Scientific, Illkirch, France) and RNA integrity evaluated on a 
2100 BioAnalyzer (Agilent Technologies, Massy Cedex, France). 
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cDNA was synthesized and labeled with biotin using Ambion 
Illumina TotalPrep RNA Amplification Kits (Applied Biosystem/
Ambion, Saint-Aubin, France). Labeled cRNA were hybridized to 
Illumina Human HT-12V4 BeadChips. All steps were performed 
following the supplier instructions. Raw and normalized micro-
array data have been deposited in the ArrayExpress database (38) 
under an accession number E-MTAB-5907.
statistical analysis and graphical 
representations
Cytometry, Luminex, and transcriptomic data were analyzed 
using R (39). Hierarchical clustering was performed based on the 
Euclidean metric using the Ward linkage method. Flow cytometry 
and Luminex measurements were normalized for heatmap rep-
resentations. Differentially expressed genes were identified using 
the paired Student’s t-test (q-value < 0.01), and based on a 1.2-fold 
change threshold to discard genes having very low amplitude of 
down- or upregulations. Multidimensional scaling (MDS) repre-
sentations were generated using the singular value decomposition 
(SVD)-MDS algorithm (40). Kruskal Stress (41) quantifies the 
quality of the MDS as the fraction of information lost during 
the dimensionality reduction process. Functional enrichment 
analysis of the differentially expressed genes was performed using 
Ingenuity Pathway Analysis software (IPA®, Qiagen, http://www.
qiagen.com/ingenuity). Statistical analysis for flow cytometry 
and Luminex data were performed using Prism® 6.0 (Graphpad 
Software Inc., La Jolla, CA, USA). Two-sided Friedman tests 
followed by a Dunn’s posttest comparing each time-point with 
the baseline were performed. Significant correlations between 
Luminex, transcriptomic, and cytometry variables were identified 
using the Pearson correlation coefficient based on a correlation 
threshold of 0.80 and a q-value threshold of 0.05. Representation of 
the co-expression network was generated using Cytoscape® (42).
resUlTs
skin infection With MVa attenuated 
Vaccine induces localized inflammatory 
immune response
Mantoux i.d. injection with rMVA expressing eGFP induced mild 
local lesions, detected as early as 24 h post injection (p.i.), which 
progressively evolved into an erythema (Figure 1A). Epidermal 
thickness increased by 24  h p.i. followed by mild parakeratosis 
48 h p.i. and epidermal cell necrosis at 72 h p.i. (Figure 1B). In the 
dermis, we observed edema, associated with moderate perivas-
cular neutrophilic and macrophage infiltration from 24 to 72 h 
p.i. There was a massive neutrophil and macrophage infiltration 
at the interface between the lower dermis and the hypodermis, 
associated with necrosis. The eGFP-expressing cells resulting from 
rMVA infection were tracked in the skin by repeated in vivo imag-
ing using FCFM (Figure 1C). Expression of eGFP was detected 
as early as 24 h p.i., peaked at 48 h (56.2 ± 59.3 cells per mm2), 
persisted at a high level until day 3 (22.8 ± 24.7 cells per mm2), 
and disappeared by day 7 (Figure 1D). This kinetic profile was 
confirmed by confocal time-lapse microscopy (Figure 1E). In skin 
biopsies collected 4 h after in vivo injection of the rMVA, the first 
eGFP signals were detected 13–15 h p.i. and reached the maximum 
level by 18–22 h (Figure 1F). Some, but not all, eGFP+ cells also 
expressed HLA-DR indicating that the detection of the recombi-
nant gene was not limited to skin APCs. In situ analysis revealed 
the heterogeneous morphology of the eGFP+ cells, which included 
DCs, macrophages, adipocytes, and granulocytes (Figure  2A). 
Most were localized to vascularized areas, such as the papillary–
reticular dermis interface and the hypodermis layer. No eGFP+ 
cells were detected in the epidermis. We further characterized the 
phenotype of the eGFP+ skin cells by performing flow cytometry 
on cell suspensions obtained from the injection site, including the 
epidermis and dermis. Cells containing locally produced eGFP 
reached a peak between 24 (25.8 ± 4.9% of total living cells) and 
48 h (19.5 ± 3.1%) p.i., persisted through 72 h (6.4 ± 5.9%), and 
completely disappeared by 168  h (Figure S4 in Supplementary 
Material), confirming our previous observations. The rMVA 
exhibited considerable cellular pleiotropism (Figure 2B) in vivo 
in NHPs, confirming previously reported observations (43, 44). 
The major targeted populations were granulocytes, monocyte/
macrophages, and lymphocytes with the proportion of infected 
cells ranging from 3 to more than 30% (Figure 2B). Granulocytes 
represented most of the locally recruited cells and were by far the 
predominant population containing eGFP antigen when normal-
ized to the number of cells per gram of tissue (Figure 2C). It is 
thus likely that this population significantly influences the mecha-
nisms that affect installation of the vaccine-specific response. The 
proportion and number of eGFP+ DCs, which are major resident 
sentinels in the skin, was low.
rMVa injection induces strong local 
Production of innate and adaptive 
Mediators
Local cellular recruitment and cytokine production were found 
to very similar over the kinetics between the three animals. Cells 
recruited to the site of injection included mainly inflammatory 
myeloid cells, with statistically significant increases in the number 
of macrophages, granulocytes, and monocytoid cells (Friedman 
test; p < 0.05), which increased at 24 and 48 h p.i. compared to 
baseline (Figure 3A). As expected, the recruitment of inflamma-
tory cells was associated with the local release of inflammatory 
cytokines and chemokines (Figure 3B). Local levels of a first cluster 
of pro-inflammatory molecules, including GM-CSF, IL-1β, IL-6, 
MIP1α, MIP1β, and TNFα, significantly increased (p < 0.05) as 
early as 24 h p.i. (no earlier time-points were tested), but then 
rapidly decreased to baseline levels by 72  h. A second cluster 
of inflammatory cytokines, including MCP1, IL-12/23(p40), 
IL-8, IL-18, and G-CSF, remained high through 72  h (no later 
time-point was tested), in contrast to the previous group. These 
molecules certainly reflect macrophage and granulocyte activ-
ity. We also observed an increase in the level of the angiogenic 
factors TGFα and VEGF, also part of the inflammation process. 
This cluster also included anti-inflammatory mediators, such as 
IL-10 and IL-1RA, for which prolonged expression is expected. 
Finally, cytokines related to an adaptive response, including IL-2 
and IL-13, were also detected in this cluster as early as 24 h p.i., 
FigUre 1 | Dynamics of local inflammation and infection after intradermal injection of rMVA. (a) Image of the skin before and after Buffer or rMVA injection. Scale 
bars correspond to 2 mm. (B) HE staining of transversal sections of non-human primate skin biopsies taken at the site of injection before or 24, 48, or 72 h after 
Buffer or rMVA injection. Scale bars correspond to 100 µm. (c) Representative images recorded by in vivo confocal endo-microscopy. Recordings were performed 
at the site of injection in the dermis (at a depth of 100 ± 35 µm in the skin) with a probe detecting fluorescent signals after excitation at a wavelength of 488 nm. 
Green fluorescence corresponds to the production of GFP in rMVA-infected cells. Scale bars correspond to 50 µm. (D) Kinetic profile of GFP+ cells in the skin after 
rMVA injection. The graph represents the mean ± SD of the number of GFP+ cells/mm2 in the 50 frames with the most GFP+ cells. (e) Representative images from 
time-lapse video-confocal microscopy of HLADR+ (in red) and GFP+ (in green) cells after i.d. injection of rMVA. Skin biopsies were observed for 22 h p.i. Acquisition 
was performed at a depth of 50–150 µm in the skin (dermis) corresponding to a stack of 10 images. Visual representations correspond to a two-dimensional 
visualization of this stack at the indicated time p.i., after cropping the region of interest. Scale bars correspond to 20 µm. (F) Kinetic profile of GFP+ cell detection in 
the dermis during the first 22 h p.i. The graph indicates the number of GFP+ cells counted for each image (1 image each 15 min). Green objects between 200 and 
4,000 µm3 were considered to be GFP+ cells. The approximate time of appearance of non-background GFP+ cells is indicated with the dotted line at 14–15 h p.i.
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indicating that local cells may contribute to the installation of 
the adaptive response, although no T or B cell recruitment was 
observed. Adaptive response mediators, including IFN-γ, IL-5, 
IL-4, IL-15, and IL-17α, were also present in a third cluster, 
detectable as early as 24 h p.i., which appeared to steadily increase 
until 72 h p.i. This group also included soluble CD40L, indicating 
FigUre 2 | rMVA infects a wide range of skin cell types. (a) In situ localization of cells infected with rMVA. Transversal sections of paraffin-embedded skin biopsies 
were stained with an anti-GFP antibody and then colored with HE. E and D indicate the epidermis and the dermis, respectively. Scale bars correspond to 100 µm. 
Arrows indicate GFP+ cells as example. (B) Percentage of rMVA-infected cells in the skin. The dot plots show the evolution of recruitment of the main immune cells 
to the skin and the percentage of GFP+ cells. (c) Number of GFP+ cells per gram of skin biopsy. The numbers of GFP+ cells in the indicated cell population were 
normalized to the weight of the skin biopsies. The graph represents the mean ± SD (n = 3). See also Figure S3 in Supplementary Material for gating strategies.
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that immunosuppressive factors are also induced, probably as a 
mechanism to limit the local reaction.
impact of rMVa intradermal injection  
on Draining lns
We collected LNs draining the vaccine injection site 24 h p.i. to 
study the dynamics of the interaction between tissues in response 
to rMVA injection. The contralateral LNs were collected as a 
control. We did not observe significant differences between LNs, 
as only three animals per group were included at only one time-
point. However, one of the animals appeared to have an increase 
in the proportion of macrophages and granulocytes in draining 
LNs (Figure 4A). This cell recruitment profile reflected the local 
increases observed in the skin. In addition, this animal also 
FigUre 3 | rMVA injection induces local cellular trafficking and cytokine release. (a) Heatmap representation of the cell counts in skin subset populations 
discriminated by flow cytometry. Cell populations were automatically sorted following hierarchical clustering represented by the dendrogram on the left. The number 
of cells was calculated by dividing the number of events by the weight of the biopsy. Values were standardized to display the same range of expression values for 
each cell population to properly visualize the cell population kinetics. See Figure S3A in Supplementary Material for gating strategies. (B) Heatmap representation of 
cytokine release in the skin after rMVA injection. Cytokine expression was automatically sorted following hierarchical clustering represented by the dendrogram. 
Values were standardized to display the same range of expression values for each cytokine to properly visualize the cytokine production kinetics. *0.05 > p-
value > 0.01 in Friedman’s test over time.
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showed an increase in the proportion of APCs, such as CD1a+ 
DCs, as well as T lymphocytes (Figure 4A). Despite important 
heterogeneity, cytokine levels measured in total LN tissue 
extracts indicated increased levels of inflammatory cytokines, 
such as IL-6, TNFα, and particularly MCP1, G-CSF, and IL-8 
(Figure 4B). This is consistent with the migration of macrophages 
and granulocytes. Additional cytokines, including IL-4, IFN-γ, 
IL-2, and IL-13, related to adaptive responses were highly 
elevated in the draining LNs. Inversely, IL-18 was found to be 
consistently decreased after MVA immunization. Finally, analysis 
of transcriptomic profiles showed increased expression of genes 
associated with the initiation of immune responses in the LN 
draining the vaccine injection site. In details, we found 49 genes 
differentially expressed between MVA and control samples, 15 
of them were upregulated while 34 of them were downregulated. 
A pathway enrichment analysis was performed on this differen-
tially expressed gene set. We identified one significantly enriched 
upstream transcriptional regulator, ATF3, associated with TLR4 
signaling (45). Other markers of activation also appeared to be 
upregulated in the draining LN without reaching a significant 
threshold likely because of the limited sample size. We used MDS 
representations to better visualize similarities and dissimilarities 
between transcriptomic profiles. This approach provides superior 
fidelity in representing the distance between different instances 
when analyzing high-dimensional geometric objects than more 
classical SVD-based methods (40). MDS analysis clearly segre-
gated the transcriptomic signature of the draining LNs from that 
of the contralateral LNs (Figure 4C).
From local reactions to systemic  
Vaccine responses
We examined the effect of local cellular and molecular events on 
systemic immunity in the blood of vaccinated animals. The number 
of blood CD66high granulocytes significantly increased (p < 0.05) 
very early (6 h) following vaccine injection (Figure 5A), consist-
ent with the inflammation described in the skin and the draining 
LN. The level of these cells peaked from 6 to 24 h p.i. and then rap-
idly decreased to reach baseline levels by 72 h p.i. The increase in 
granulocyte levels in the blood preceded their recruitment to the 
skin. Classical monocyte (CD14+CD16−) numbers also increased 
in the blood by 6 h p.i., but then rapidly decreased by 24 h p.i., 
probably due to their differentiation into pro-inflammatory 
FigUre 4 | Immune reaction in the draining lymph nodes (LNs). (a) Heatmap representation of cell populations discriminated by flow cytometry in the inguinal LNs 
draining the sites of rMVA injection (dLNs) and the contralateral LNs (Non dLNs). Cell populations were automatically sorted following hierarchical clustering 
represented by the dendrogram on the left. The cell count/gram was calculated by dividing the number of events by the weight of the biopsies, which were collected 
24 h p.i. Values were standardized to display the same range of expression values for each cell population to properly visualize the cell population kinetics. See 
Figure S3B in Supplementary Material for gating strategies. (B) Heatmap representation of cytokine release in the LNs after rMVA injection. Cytokine production was 
automatically sorted following hierarchical clustering represented by the dendrogram. Values were standardized to display the similar range of expression for each 
cytokine to properly visualize the cytokine production kinetics. (c) Multidimensional scaling representation of transcriptomic signatures in LNs 24 h after rMVA 
injection. Biological samples are represented as dots in a two-dimensional space. The distances between the dots are proportional to the Euclidian distances 
between the transcriptomic profiles.
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(CD14+CD16+) and non-classical (CD14−CD16+) monocytes, 
which indeed increased by 24 and 72 h, respectively. The increase 
in classical monocyte numbers also preceded the recruitment of 
monocyte/macrophages to the skin, similarly to granulocytes. 
In contrast to the myeloid populations, the number of T and B 
lymphocytes, NK cells, and pDCs strongly decreased in the blood 
early after vaccine injection (6 h), and then reappeared later, prob-
ably due to their migration to the sites of injection and draining 
lymphoid tissues. We also observed an increase (p = 0.0559) in 
the number of CD14+HLADR−CD33+ cells, expressing a pheno-
type corresponding to myeloid-derived suppressor cells (CD14+ 
MDSCs), at 24  h p.i., preceded by a transient increase in the 
number of early-stage Lin− MDSCs-like cells (46), between 6 and 
24 h p.i. Early appearance of these cells may represent a natural 
mechanism to control initial inflammatory processes.
Cytokine titration indicated that IL-6 levels transiently 
increase from 6 to 24 h in blood along with molecules associated 
with acute inflammation, such as IL-1β, MIP1α/β, and MCP1, 
which persisted in the blood through 72 h p.i. (Figure 5B). These 
cytokine profiles were similar to those observed in the skin. 
In contrast, TNFα clearly exhibited different kinetics in skin 
and blood, suggesting specific roles in the two compartments. 
We observed similar differences for IL-12 and TGFα. In addition, 
the levels of cytokines associated with adaptive responses, includ-
ing IL-2, IL-4, IL-17α, IL-15, and IL-5, progressively increased 
up to the latest time-point (72  h) of the study. The cytokine 
titration profile in blood (Figure 5B) was clearly distinct from 
that of the skin (Figure 3B), suggesting that the cytokines found 
in the blood vessels of the skin had little, if any, influence on the 
cytokines measured in total tissue extracts.
We found a total of 742 genes differentially expressed in at least 
one time-point relative to control samples. A total of 123 genes 
were found to be down- or upregulated at 6 h, 354 genes at 24 h, 
361 genes at 48 h, and 89 genes at 78 h. MDS analysis restricted 
to the set of differentially expressed genes in blood revealed a 
clear segregation between time-points (Figure 5C). The 24 h p.i. 
time-point was the most distant from the baseline. Gene expres-
sion levels 6 and 48 h p.i. showed an intermediate distance from 
baseline and had close gene expression profiles. Although the 
72 h p.i. profile was the closest to the baseline values, it remained 
significantly distant. Functional enrichment analysis revealed that 
the expression levels of genes associated with several canonical 
pathways and upstream regulators were significantly modified 
(p-value < 10−3) in blood cells (Figure 5D). Genes associated with 
FigUre 5 | Systemic effects of intradermal rMVA injection. (a) Heatmap representation of blood cell populations discriminated by flow cytometry. Cell populations 
were automatically sorted following hierarchical clustering represented by the dendrogram on the left. The number of cells/milliliter was calculated using the number 
of leukocytes obtained by complete blood count analysis. Values were standardized to display the same range of expression values for each cell population to 
properly visualize the cell population kinetics. See Figures S3C,D in Supplementary Material for gating strategies. (B) Heatmap representation of cytokine release in 
the blood after rMVA injection. Plasma cytokine titrations were automatically sorted following hierarchical clustering represented by the dendrograms on the left. 
Values were standardized to display the same range of expression for each cytokine to properly visualize the cytokine production kinetics. (c) Multidimensional 
scaling representation of transcriptomic signatures in the blood after rMVA injection. Biological samples are represented as dots in a two-dimensional space. The 
distances between the dots are proportional to the Euclidian distances between the transcriptomic profiles. (D) Heatmap representation of functional enrichment. 
Data were extracted from differentially expressed genes relative to the baseline condition and functional enrichment expressed as −log(p-value), with a cutoff 
−log(p-value) > 3 for at least one time-point. Only differentially expressed canonical pathways and upstream regulators linked to the immune response are 
represented. Arrows correspond to the sign of the z-score, indicating the orientation of the expression of the group of genes (n = 3). *0.05 > p-value > 0.01; 
**0.01 > p-value > 0.001; ***0.001 > p-value in Friedman’s test over time.
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the inflammatory response (TNFα, IL-6, IL-32, and acute phase 
response signaling) were upregulated at early time-points, consist-
ent with changes in the cellular composition in blood and cytokine 
levels in plasma. In contrast and consistent with T-cell migration 
out of blood circulation, canonical pathways and regulators that 
contribute to the lymphocytic response, such as IL-2, CD28 signal-
ing, and iCOS-iCOSL signaling, were downregulated. Transcripts 
that regulate important innate canonical pathways, e.g., antigen 
presentation pathways, CCR5 signaling in macrophages, IL-10 
signaling, or NK-DCs crosstalk, showed some change without any 
overall clear up- or downregulation (Figure 5D).
co-expression network representation 
highlights the Predominant Factors 
involved in the early Vaccine response
We integrated our data in a global analysis to provide a compre-
hensive overview of the early immune reaction following vaccina-
tion. We calculated Pearson correlations (cutoff: |R| >  0.8 and 
q-value < 0.05) for the whole dataset to establish links between 
the parameters of the three studied compartments (Tables S1 
and S2 in Supplementary Material). This led to the construc-
tion of a co-expression network where the nodes correspond 
to the biological variables and the connecting lines correspond 
to significant correlations (degree of connectivity) between two 
variables (Figure  6). Non-draining LNs were considered to be 
the untreated conditions of draining LNs. The parameters were 
organized according to their type (cell, cytokine, or gene) and 
their origin (skin, blood, or LN). Parameters that did not lead to 
significant correlations are not represented. Cytokines measured 
in the skin strongly correlated with cytokines in draining LNs 
(48 connections), including inflammatory mediators such as 
TNFα, MIP1β, IL-6, and IL-1β, as well as factors associated with 
monocyte/macrophage and granulocyte recruitment, e.g., TGFα, 
G-CSF, and GM-CSF. Cytokines produced in the skin were strongly 
associated with gene products of the LNs (41 connections). 
However, three out of four of these gene products had unknown 
functions; the fourth (PLK1) is involved in cell proliferation. 
Blood and skin were also connected through their cytokines, but 
to a lesser extent (35 connections), with TNFα and TGFα empha-
sizing again the role of granulocytes and monocyte/macrophages 
and IL-17α, IL-15, IL-5, and IL-12/23 suggesting the impact 
of the injection site on installation of the adaptive response. In 
addition, CD14+ MDSCs from the blood strongly correlated 
with cytokines produced in the skin (11 connections). Gene 
products from the blood represented the largest group connected 
to the other parameters (38 genes with significant correlations). 
The gene products with the highest degree of connectivity 
were involved in the regulation of apoptosis (MAGED1), cell 
activation (DDT, GNLY, GNB2L1), cellular signaling pathways 
(RASAL3, PRKCH), cell mobility (GRK5), and cell proliferation 
(LAS1L, NUSAP1, HINT2, KIF22, EML3, CENPB, REXO1, 
PARP9, ELF2). In addition, these gene products from the blood 
were strongly connected to the pro-inflammatory cytokine 
IL-18 produced in the LNs (28 connections). We also organized 
the correlated biological parameters according to their peak of 
expression over the time following vaccine injection to evaluate 
the chronology of the events (Figure  7). This representation 
associated the blood, skin, and the LNs at 24 h p.i., at the peak 
of the inflammatory response, with monocyte/macrophages, 
granulocytes, and related cytokines as major actors. This kinetic 
profile confirmed the early involvement of actors of inflamma-
tion relative to those of the adaptive responses. In addition, it 
also showed that the control of the inflammatory responses was 
initiated early, with Lin− MDSCs detected in the blood 6 h p.i. and 
CD14+ MDCS 24 h p.i.
DiscUssiOn
Here, we aimed to better understand how cellular and molecular 
vaccine-induced innate immune parameters are interacting each 
other and how they could contribute elicit a vaccine response pro-
file. To our knowledge, this study remains the first to characterize 
simultaneously local and systemic early kinetics in NHP model 
after vaccination. For this purpose, we used systems vaccinol-
ogy approaches to integrate innate parameters for identifying 
key factors that can impact the adaptive responses. We used a 
multimodal analysis strategy to characterize the early steps of the 
immune response to MVA infection, at the local site of injection, 
in the draining LN, and blood. The MVA cell infection started 
15  h p.i., involved several cell populations, and persisted for 
3 days. The local innate response was characterized by early mas-
sive recruitment of granulocytes, macrophages, and monocytoid 
cells, associated with local production of GM-CSF, IL-1β, MIP1α, 
MIP1β, and TNFα. The innate response was also initiated at the 
systemic level with rapid and transient granulocyte recruitment 
and the release of IL-6 and IL-1RA, from 6 to 24 h p.i., followed by 
a persistent phase involving inflammatory monocytes. Systemic 
inflammation was confirmed by molecular signatures, such as 
those of genes that upregulate the IL-6 and TNF pathways and 
acute phase response signaling. Finally, integration of the data in 
a co-expression network allowed visualization of the relationships 
between the three compartments and the chronology of the events.
As a modified form of the vaccinia virus, MVA binds to a wide 
range of host cells and fuses with the cell membrane without the 
requirement of specific cell receptors, but the ability to fully com-
plete the replication cycle is dependent on downstream intracel-
lular events (44). The impaired ability of MVA to fully replicate in 
mammalian cells (47) has no apparent effect on recombinant gene 
expression (48). These properties are consistent with the detec-
tion of the recombinant gene (eGFP) in several cell subsets and 
the broad stimulation of innate immunity, suggesting that our 
observations are representative of diverse rMVA vectors express-
ing vaccine antigens, such as HCV, HIV, HBV, Ebola, malaria. By 
infecting a large variety of cells, MVA is widely sensed by several 
PRRs, such as TLR2, TLR6, MDA5, NALP3 inflammasome 
pathways (11), or cGAS (49). These PRRs are expressed in several 
resident cell types of the skin, including immune cells, as well as 
keratinocytes (50). Consequently, the recruitment of inflamma-
tory cells, mostly originating from the blood, was expected as a 
part of the early response to the vaccine (6, 51).
We observed no clear-cut DC migration, which was pos-
sibly outshone by the magnitude of the inflammatory response. 
Pathogen sensing and the important cellular trafficking observed 
FigUre 6 | Co-expression network showing the correlations between each biological variable evaluated. Data were sorted in groups depending on the 
compartment (blood, lymph node, or skin) and type (cytokine, cell, or gene). Variables were then sorted depending on their size which is proportional to the number 
of correlations (degree of connectivity) they establish. All lines linking two parameters correspond to significant correlations between these variables (|R| > 0.8, 
q-value < 0.05).
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are likely associated through the microenvironment modifica-
tions mediated by local cytokine release, particularly G-CSF, 
GM-CSF, IL-1β, IL-6, MIP1β, and TNFα which contribute to 
the recruitment of granulocytes and macrophages and increase 
their cytotoxic activity and migration to the inflammation site. 
This localized cytokine release, along with local apoptosis of 
FigUre 7 | Co-expression network based on the kinetics of recruitment of key effectors of the Modified virus Ankara-induced innate response. The most highly 
correlated variables (degree of connectivity > 10) were sorted according to their compartment, their type, and their kinetics of expression after rMVA injection.
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granulocytes, led to resolution of the inflammation (52), shown 
by the decrease of pro-inflammatory cytokine levels and the 
increase of IL-2 and IL-15, opening the way to potential local 
specific T-lymphocyte responses.
The local immune response to rMVA was associated with 
considerable systemic inflammation which was initiated before 
the detection of the first infected cells expressing the recombi-
nant antigen (eGFP). We postulate that the first immune signals 
were delivered by resident skin cells through inflammatory 
eicosanoid mediators soon after rMVA administration (52), 
leading to rapid granulocyte release from the bone marrow and 
migration to the site of injection through the blood. The level of 
IL-6 and IL-1RA and the upregulation of acute response path-
ways 6–24 h p.i. may be associated with the increase of granu-
locytes in the blood. The downregulation of several pathways 
related to lymphocyte responses could be linked with a decrease 
of lymphocytes in the blood. In addition to lymphocytes, CD16− 
NK cells and CD33+ DCs also left the systemic compartment, 
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but were not observed at the site of injection. They may modify 
their phenotype upon migration and differentiation and later 
migrate directly to the LNs.
The correlations between the biological parameters suggest 
that the magnitude of the inflammatory response directly orches-
trates the early steps of the adaptive response. This is illustrated by 
the early correlations between IL-2 levels in the skin and LNs. In 
addition to TNFα, this cytokine leads to a Th1 response, consistent 
with the primary T cell response profile induced by MVA (43, 53). 
We also identified IL-15 as an early key parameter detected in 
the skin and in the blood. This cytokine vastly associated with 
IL-2 and mainly produced by monocytes and macrophages could 
also modulate the immune response toward a Th1 profile (54). 
However, our analysis also revealed the coexistence of effectors 
of the Th2 response, such as IL-4, IL-5, IL-10, and IL-13, in the 
LN. Moreover, the level of the pro-inflammatory cytokine IL-18, 
which is associated with orientation toward the Th1 response, was 
decreased after MVA immunization and thus inversely correlated 
with several recruited cell types and cytokines. It may, however, 
be a signature of inflammasome activation in subcapsular mac-
rophages before 24 h p.i and thus be consistent with MVA-induced 
responses observed in mouse models (55). The MVA genome 
lacks functional copies of many genes that normally interfere with 
the host response to infection. Nevertheless, despite the strong 
inflammatory reaction, the only significantly modified upstream 
regulator associated with type 1 IFN gene was downregulated 
and only detected at 72 h p.i. in the blood. This might reflect the 
presence of interferon resistance genes, such as E3L, which is still 
functional in MVA (56).
The co-expression network highlighted interactions between 
the innate effectors by revealing hubs within the kinetics of the 
global immune response. Notably, it allowed identification of 
critical immune mediators, such as TNFα and MDSCs. TNFα 
was expected to be a key factor of the innate response as it is 
a central pro-inflammatory cytokine. This cytokine is indeed 
produced and released by granulocytes and macrophages and 
delivers signals leading to tissue necrosis. In certain contexts, 
TNFα could activate Langerhans cells (6), and induce T  cell 
responses (57). The recruitment of CD14+ MDSCs was unex-
pected, since these cells are described to be mainly associated 
with immunosuppressive processes, such as tumor immune 
evasion and lymphocyte suppression through the production of 
reactive oxygen species (58, 59). Nevertheless, similar MDSCs 
were observed in the blood in rMVA-SIV vaccinated macaques 
and were found to exert T CD8+ suppression in  vitro (60). In 
vaccine development studies, the induction of MDSCs was 
associated with the use of adjuvants (61, 62). Our results show 
that the involvement of MDSCs occurred as early as 24  h p.i., 
indicating that the resolution of the anti-MVA response may start 
very early. Further studies would be necessary to define whether 
the biological signatures identified in this model would be shared 
with the responses to other vaccines.
Our original approach combining in vivo imaging, histology, 
flow cytometry, multiplex cytokine analysis, and transcriptomic 
analysis using tools derived from systems biology, such as cor-
relation networks, shows that the vaccine-induced immune 
response is a continuum of events which influence and synergize 
with each other. Out of note, we took advantage of these bioin-
formatic tools to statistically capture, in an efficient manner, this 
expression continuum with a limited number of animals. These 
synergies correspond to a cascade of reactions that depend on the 
original stimulus. We showed that the magnitude of the response 
of early effectors, such as local granulocytes and TNFα release, 
are directly associated with the first steps of the orientation of 
the adaptive response in the draining LNs. Furthermore, MDSCs 
should be considered to be a potential component of the signature 
of the response. Identification of such signatures should improve 
our understanding on how to effectively orientate the immune 
response, and could contribute to rational vaccine development.
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